Vericel Corp. (VCEL)
40.15
+0.71
(+1.80%)
USD |
NASDAQ |
Oct 02, 16:00
40.15
0.00 (0.00%)
After-Hours: 20:00
Vericel Price to Book Value : 5.552 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 5.552 |
| October 01, 2026 | 5.454 |
| September 30, 2026 | 5.551 |
| September 29, 2026 | 5.616 |
| September 28, 2026 | 5.565 |
| September 25, 2026 | 5.491 |
| September 24, 2026 | 5.435 |
| September 23, 2026 | 5.364 |
| September 22, 2026 | 5.562 |
| September 21, 2026 | 5.469 |
| September 18, 2026 | 5.534 |
| September 17, 2026 | 5.536 |
| September 16, 2026 | 5.560 |
| September 15, 2026 | 5.493 |
| September 14, 2026 | 5.476 |
| September 11, 2026 | 5.302 |
| September 10, 2026 | 5.237 |
| September 09, 2026 | 5.392 |
| September 08, 2026 | 5.404 |
| September 04, 2026 | 5.558 |
| September 03, 2026 | 5.596 |
| September 02, 2026 | 5.654 |
| September 01, 2026 | 5.600 |
| August 31, 2026 | 5.518 |
| August 28, 2026 | 5.663 |
| Date | Value |
|---|---|
| August 27, 2026 | 5.695 |
| August 26, 2026 | 5.869 |
| August 25, 2026 | 5.977 |
| August 24, 2026 | 5.849 |
| August 21, 2026 | 5.902 |
| August 20, 2026 | 5.823 |
| August 19, 2026 | 6.025 |
| August 18, 2026 | 6.120 |
| August 17, 2026 | 6.028 |
| August 14, 2026 | 6.112 |
| August 13, 2026 | 6.159 |
| August 12, 2026 | 6.186 |
| August 11, 2026 | 6.133 |
| August 10, 2026 | 6.078 |
| August 07, 2026 | 6.235 |
| August 06, 2026 | 6.188 |
| August 05, 2026 | 6.273 |
| August 04, 2026 | 6.408 |
| August 03, 2026 | 6.368 |
| July 31, 2026 | 6.356 |
| July 30, 2026 | 6.584 |
| July 29, 2026 | 6.447 |
| July 28, 2026 | 6.459 |
| July 27, 2026 | 6.267 |
| July 24, 2026 | 6.230 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| ADMA Biologics, Inc. | 5.366 |
| Kyntra Bio, Inc. | -- |
| Conexeu Sciences, Inc. | 14.52 |
| ACADIA Pharmaceuticals, Inc. | 2.628 |
Price to Book Value Related Metrics
| PE Ratio | 86.85 |
| PS Ratio | 6.786 |
| PEG Ratio | 0.3204 |
| Price to Free Cash Flow | 33.71 |
| Price | 40.15 |
| Earnings Yield | 1.15% |
| Market Cap | 2.055B |
| PEGY Ratio | 0.3204 |
| Operating PE Ratio | 113.98 |
| Normalized PE Ratio | 86.87 |